Optimal delivery of follow-up care after surgery for Crohn’s disease: current perspectives

por Campbell, James P, Vaughn, Byron P
Publicado 2016

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

por Campbell, James P., Zierold, Claudia, Rode, Ashli M., Blocki, Frank A., Vaughn, Byron P.
Publicado 2021

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

por Vaughn, Byron P., Yarur, Andres J., Graziano, Elliot, Campbell, James P., Bhattacharya, Abhik, Lee, Jennifer Y., Gheysens, Katherine, Papamichael, Konstantinos, Osterman, Mark T., Cheifetz, Adam S., Cross, Raymond K.
Publicado 2020

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

por Lukin, Dana, Faleck, David, Xu, Ronghui, Zhang, Yiran, Weiss, Aaron, Aniwan, Satimai, Kadire, Siri, Tran, Gloria, Rahal, Mahmoud, Winters, Adam, Chablaney, Shreya, Koliani-Pace, Jenna L., Meserve, Joseph, Campbell, James P., Kochhar, Gursimran, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Boland, Brigid, Singh, Siddharth, Hirten, Robert, Ungaro, Ryan, Lasch, Karen, Shmidt, Eugenia, Jairath, Vipul, Hudesman, David, Chang, Shannon, Swaminath, Arun, Shen, Bo, Kane, Sunanda, Loftus, Edward V., Sands, Bruce E., Colombel, Jean-Frederic, Siegel, Corey A., Sandborn, William J., Dulai, Parambir S.
Publicado 2020